As discussed above, under inflammatory conditions, B cells produce higher amounts of RANKL, leading to an increased RANKL/OPG ratio, which drives disease progression (26, 29) in inflammatory diseases such as RA. This evidence concerns the gene TNFRSF11B and rheumatoid arthritis.